Product Information

TOPIRAMATE ER 100 MG SPRINK CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $6.0614 per EA under NDC 00832107430. Its NADAC has been published 571 times since Jul 22, 2015.

FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 100 MG SPRINK CAP

Topiramate
$6.0614per EA

Strength

100 mg/1

NDC

00832107430

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TOPIRAMATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA205122

FDA Approved

3/11/2014

TE Code

AB2

On Market Since

7/7/2014

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has been published 571 times since Jul 22, 2015, and over the history we have for it it has declined 40.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.0614 per EA
All-time high$17.6424 (Sep 15, 2021)
All-time low$5.3243 (Jul 22, 2026)
52-week high$8.5014
52-week low$5.3243
Median price$13.0168
Average price$12.7685
Largest weekly change+27.3% (Sep 20, 2023)
Weeks tracked571
Tracking sinceJul 22, 2015

Price History

1W

+4.9%

1M

+10.4%

3M

+12.6%

6M

+7.0%

1Y

-28.2%

3Y

-43.4%

5Y

-65.1%

All

-40.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 100 MG SPRINK CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG SPRINK CAP, manufactured by Upsher-Smith Laboratories LLC, is $6.0614 per EA (NDC 00832107430), effective Nov 18, 2026.

How has the price of TOPIRAMATE ER 100 MG SPRINK CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has declined 40.1%. It has been tracked across 571 weekly CMS publications since Jul 22, 2015.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG SPRINK CAP?

Since Jul 22, 2015, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has ranged from a low of $5.3243 (Jul 22, 2026) to a high of $17.6424 (Sep 15, 2021), with a median of $13.0168 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 100 MG SPRINK CAP?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 100 MG SPRINK CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 100 MG SPRINK CAP?

TOPIRAMATE ER 100 MG SPRINK CAP (NDC 00832107430) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.